Paolo Tarantino/LinkedIn
Feb 11, 2025, 10:28
Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Back to Porto for a lecture on novel treatments for HR+/HER2- metastatic breast cancer, 11 years after completing my med school year abroad in this city.
Still remains one of the most charming and inspiring places I know.
Thanks to the team at the Portuguese Institute of Oncology of Porto (IPO-Porto) for having me!”
More posts featuring Paolo Tarantino.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26